NeuroSense Therapeutics | Investor Presentation Deck | 33 slides · page 8 of 33
The chart uses hazard ratio as a metric for efficacy in an iPSC model derived from ALS patients.
Pitch deck · traction · show_traction · dense density
Slide locked Sign in to view
Slide schematic 5/5
chart 1/1 disclaimer 1/1 paragraph 1/1 source-note 1/1 title 1/1
Components 5
bar-vertical disclaimer paragraph source-note headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.